Your browser doesn't support javascript.
loading
Modeling time-delayed concentration-QT effects with ACT-1014-6470, a novel oral complement factor 5a receptor 1 (C5a1 receptor) antagonist.
Anliker-Ort, Marion; Hsin, Chih-Hsuan; Krause, Andreas; Pfister, Marc; van den Anker, John; Dingemanse, Jasper; Kaufmann, Priska.
Afiliación
  • Anliker-Ort M; Department of Clinical Pharmacology, Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland.
  • Hsin CH; Pediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel (UKBB), University of Basel, Basel, Switzerland.
  • Krause A; Department of Clinical Pharmacology, Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland.
  • Pfister M; Department of Clinical Pharmacology, Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland.
  • van den Anker J; Pediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel (UKBB), University of Basel, Basel, Switzerland.
  • Dingemanse J; Pediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel (UKBB), University of Basel, Basel, Switzerland.
  • Kaufmann P; Department of Clinical Pharmacology, Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland.
Pharmacol Res Perspect ; 11(4): e01112, 2023 08.
Article en En | MEDLINE | ID: mdl-37470156

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factor Va Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Pharmacol Res Perspect Año: 2023 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factor Va Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Pharmacol Res Perspect Año: 2023 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos